{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:13:04Z","timestamp":1785928384306,"version":"3.56.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:p>Myocyte enhancer binding factor 2B (MEF2B) is a transcriptional activator of the <jats:italic toggle=\"yes\">BCL6<\/jats:italic> proto-oncogene in normal germinal center (GC) B-cells. Limited data exists concerning its expression in B-cell lymphomas, and comparison with other GC-associated antigens is lacking. Its role in the differential diagnosis of B-cell lymphomas, particularly in the distinction of follicular lymphoma (FL) versus marginal zone lymphoma (MZL), remains to be determined. We evaluated MEF2B expression, in comparison with additional GC markers, LIM domain-only transcription factor 2 (LMO2), and human GC-associated lymphoma (HGAL), in a variety of B-cell lymphomas, with particular emphasis on their utility in differentiating FL from MZL. MEF2B was positive in all FL and Burkitt lymphomas, 8\/9 mantle cell lymphomas, 2\/24 splenic MZL, 1\/10 chronic lymphocytic leukemia\/small lymphocytic lymphomas, and 38\/44 diffuse large B-cell lymphoma (DLBCL), but was negative in all extranodal MZL of mucosa-associated lymphoid tissue, nodal MZL, and B-lymphoblastic lymphomas. Focusing on low-grade FL versus MZL, MEF2B was 100% sensitive and 95% specific for FL, which was similar to BCL6, but superior to LMO2 (sensitivity 87%, specificity 86%) and HGAL (sensitivity 97%, specificity 86%). Importantly, MEF2B was positive in 4\/4 FL with plasmacytoid differentiation, which were CD10<jats:sup>\u2212<\/jats:sup>, only weakly BCL6<jats:sup>+<\/jats:sup>, and included 1 case that lacked both LMO2 and HGAL expression. MEF2B was positive in 22\/25 (88%) GC-type DLBCL, but was also positive in 16\/19 (61%) non\u2013GC-type DLBCL. MEF2B shows superior sensitivity and specificity than LMO2 and HGAL in the differential diagnosis of FL versus MZL and is particularly useful in FL with plasmacytoid differentiation, which may have morphologic and immunophenotypic overlap with MZL. MEF2B, however, is not specific for GC-derived B-cell lymphomas as it is also apparently positive in most mantle cell lymphoma and many non\u2013GC-type DLBCL.<\/jats:p>","DOI":"10.1097\/pas.0000000000001015","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T01:59:45Z","timestamp":1515376785000},"page":"342-350","source":"Crossref","is-referenced-by-count":14,"title":["Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas"],"prefix":"10.1097","volume":"42","author":[{"given":"Erika M.","family":"Moore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H.","family":"Swerdlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20240215","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization (WHO) classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"R2-20240215","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1023\/A:1008265532487","article-title":"Epidemiology of the non-Hodgkin\u2019s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin\u2019s Lymphoma Classification Project","volume":"9","author":"Anderson","year":"1998","journal-title":"Ann Oncol"},{"key":"R4-20240215","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1746-1596-6-97","article-title":"Comparison of germinal center markers CD10, BCL6 and human germinal center-associated lymphoma (HGAL) in follicular lymphomas","volume":"6","author":"Goteri","year":"2011","journal-title":"Diagn Pathol"},{"key":"R5-20240215","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/his.12076","article-title":"Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroups","volume":"62","author":"Marafioti","year":"2013","journal-title":"Histopathology"},{"key":"R6-20240215","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/modpathol.2009.146","article-title":"Follicular lymphomas with plasmacytic differentiation include two subtypes","volume":"23","author":"Gradowski","year":"2010","journal-title":"Mod Pathol"},{"key":"R7-20240215","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1309\/AJCPZQ1GXBBNG8OG","article-title":"Immunoarchitectural patterns in nodal marginal zone B-cell lymphoma","volume":"132","author":"Salama","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"R8-20240215","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1309\/AJCPHPVH4M7MTWUN","article-title":"Immunoarchitectural patterns of germinal center antigens including LMO2 assist in the differential diagnosis of marginal zone lymphoma vs follicular lymphoma","volume":"140","author":"Dyhdalo","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"R9-20240215","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2141.2012.09178.x","article-title":"In non-follicular lymphoproliferative disorders, IGH\/BCL2-fusion is not restricted to chronic lymphocytic leukaemia","volume":"158","author":"Baseggio","year":"2012","journal-title":"Br J Haematol"},{"key":"R10-20240215","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1182\/blood-2004-08-3112","article-title":"Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation","volume":"105","author":"Natkunam","year":"2005","journal-title":"Blood"},{"key":"R11-20240215","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/PAS.0b013e3181e9343d","article-title":"Immunoarchitectural patterns in follicular lymphoma: efficacy of HGAL and LMO2 in the detection of the interfollicular and diffuse components","volume":"34","author":"Younes","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R12-20240215","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/PAI.0b013e31826399aa","article-title":"Usefulness of HGAL and LMO2 immunohistochemistry in the identification of follicular lymphomas of the non-gastric gastrointestinal tract","volume":"21","author":"Chapman-Fredricks","year":"2013","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R13-20240215","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/PAI.0000000000000107","article-title":"Diagnostic utility of the germinal center-associated markers GCET1, HGAL, and LMO2 in hematolymphoid neoplasms","volume":"23","author":"Menter","year":"2015","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R14-20240215","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1309\/AJCP7Z2BIBUNQPLZ","article-title":"The efficacy of HGAL and LMO2 in the separation of lymphomas derived from small B cells in nodal and extranodal sites, including the bone marrow","volume":"135","author":"Younes","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"R15-20240215","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1182\/blood-2006-08-039024","article-title":"The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas","volume":"109","author":"Natkunam","year":"2007","journal-title":"Blood"},{"key":"R16-20240215","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2559.2012.04198.x","article-title":"Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody","volume":"61","author":"Agostinelli","year":"2012","journal-title":"Histopathology"},{"key":"R17-20240215","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1309\/9QKE68QU7B825A3U","article-title":"Expression of the serpin centerin defines a germinal center phenotype in B-cell lymphomas","volume":"130","author":"Paterson","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"R18-20240215","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1182\/blood-2007-06-094151","article-title":"Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas","volume":"111","author":"Montes-Moreno","year":"2008","journal-title":"Blood"},{"key":"R19-20240215","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00428-015-1796-6","article-title":"Pattern of MEF2B expression in lymphoid tissues and in malignant lymphomas","volume":"467","author":"Kren\u00e1cs","year":"2015","journal-title":"Virchows Arch"},{"key":"R20-20240215","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/ni.2688","article-title":"MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma","volume":"14","author":"Ying","year":"2013","journal-title":"Nat Immunol"},{"key":"R21-20240215","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.humpath.2009.09.007","article-title":"Defining the borders of splenic marginal zone lymphoma: a multiparameter study","volume":"41","author":"Dufresne","year":"2010","journal-title":"Hum Pathol"},{"key":"R22-20240215","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"R23-20240215","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00000478-199802000-00008","article-title":"CD5+ low-grade marginal zone B-cell lymphomas with localized presentation","volume":"22","author":"Ballesteros","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"R24-20240215","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/jcp.52.11.849","article-title":"CD10 positive thyroid marginal zone non-Hodgkin lymphoma","volume":"52","author":"Millar","year":"1999","journal-title":"J Clin Pathol"},{"key":"R25-20240215","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3324\/haematol.11927","article-title":"Chromosomal translocations involving BCL6 in MALT lymphoma","volume":"93","author":"Ye","year":"2008","journal-title":"Haematologica"},{"key":"R26-20240215","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1200\/JCO.2007.13.0690","article-title":"LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab","volume":"26","author":"Natkunam","year":"2008","journal-title":"J Clin Oncol"},{"key":"R27-20240215","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.humpath.2014.04.004","article-title":"Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphoma","volume":"45","author":"Metcalf","year":"2014","journal-title":"Hum Pathol"},{"key":"R28-20240215","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.humpath.2016.09.011","article-title":"Immunohistochemical analysis of the novel marginal zone B-cell marker IRTA1 in malignant lymphoma","volume":"59","author":"Ikeda","year":"2017","journal-title":"Hum Pathol"},{"key":"R29-20240215","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/his.13015","article-title":"Recurrent mutations in genes involved in nuclear factor-\u03baB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications","volume":"70","author":"van den Brand","year":"2017","journal-title":"Histopathology"},{"key":"R30-20240215","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/leu.2015.355","article-title":"SOX11 defines two different subtypes of mantle cell lymphoma through transcriptional regulation of BCL6","volume":"30","author":"Palomero","year":"2016","journal-title":"Leukemia"},{"key":"R31-20240215","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/PAS.0000000000000839","article-title":"LMO2-negative expression predicts the presence of myc translocations in aggressive B-cell lymphomas","volume":"41","author":"Colomo","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R32-20240215","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/ajcp\/aqv024","article-title":"LMO2 is a specific marker of T-lymphoblastic leukemia\/lymphoma","volume":"145","author":"Jevremovic","year":"2016","journal-title":"Am J Clin Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201803000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T07:07:59Z","timestamp":1707980879000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201803000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001015","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}